--2025/Q1-- / 762.000K--
--2024/Q4-- / 844.110K--
--2024/Q32.172M / 576.440K--
--2024/Q21.863M / 322.750K--
--2024/Q1874.000K / 371.400K--
Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
Oracle
ORCL
US Stock MarketDetailed Quotes
DNTH Dianthus Therapeutics
- 25.570
- -0.130-0.51%
Close Dec 3 16:00 ET
- 25.570
- 0.0000.00%
Post 16:02 ET
756.79MMarket Cap-11190P/E (TTM)
25.975High24.000Low354.68KVolume25.400Open25.700Pre Close8.91MTurnover2.84%Turnover RatioLossP/E (Static)29.60MShares33.77052wk High2.24P/B319.23MFloat Cap6.58052wk Low--Dividend TTM12.48MShs Float336.000Historical High--Div YieldTTM7.69%Amplitude5.136Historical Low25.121Avg Price1Lot Size
Dianthus Therapeutics Key Stats
Dianthus Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Dianthus Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data